Skip to main content

CVT-510, a novel selective A(1)-adenosine receptor agonist, terminates supraventricular tachycardia

Publication ,  Conference
Prystowsky, E; Niazi, I; Curtis, AB; Dhalla, A; Bahnson, TD; Bloomfield, D; Gold, MR; Kadish, AH; Belardinelli, L; Shreeniwas, R; Wolff, AA
Published in: CIRCULATION
October 31, 2000

Duke Scholars

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 31, 2000

Volume

102

Issue

18

Start / End Page

672 / 672

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Prystowsky, E., Niazi, I., Curtis, A. B., Dhalla, A., Bahnson, T. D., Bloomfield, D., … Wolff, A. A. (2000). CVT-510, a novel selective A(1)-adenosine receptor agonist, terminates supraventricular tachycardia. In CIRCULATION (Vol. 102, pp. 672–672). LIPPINCOTT WILLIAMS & WILKINS.
Prystowsky, E., I. Niazi, A. B. Curtis, A. Dhalla, T. D. Bahnson, D. Bloomfield, M. R. Gold, et al. “CVT-510, a novel selective A(1)-adenosine receptor agonist, terminates supraventricular tachycardia.” In CIRCULATION, 102:672–672. LIPPINCOTT WILLIAMS & WILKINS, 2000.
Prystowsky E, Niazi I, Curtis AB, Dhalla A, Bahnson TD, Bloomfield D, et al. CVT-510, a novel selective A(1)-adenosine receptor agonist, terminates supraventricular tachycardia. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2000. p. 672–672.
Prystowsky, E., et al. “CVT-510, a novel selective A(1)-adenosine receptor agonist, terminates supraventricular tachycardia.” CIRCULATION, vol. 102, no. 18, LIPPINCOTT WILLIAMS & WILKINS, 2000, pp. 672–672.
Prystowsky E, Niazi I, Curtis AB, Dhalla A, Bahnson TD, Bloomfield D, Gold MR, Kadish AH, Belardinelli L, Shreeniwas R, Wolff AA. CVT-510, a novel selective A(1)-adenosine receptor agonist, terminates supraventricular tachycardia. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2000. p. 672–672.

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 31, 2000

Volume

102

Issue

18

Start / End Page

672 / 672

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology